Rational medication in clinical practice for COVID-19 guided by Shanghai expert consensus
10.3760/cma.j.issn.1674-2397.2021.01.002
- VernacularTitle:合理用药，科学施治——谈"上海共识"指导下的新型冠状病毒肺炎临床用药
- Author:
Yuyi ZHANG
;
Hongzhou LU
- From:
Chinese Journal of Clinical Infectious Diseases
2021;14(1):7-12
- CountryChina
- Language:Chinese
-
Abstract:
The outbreak of COVID-19 occurred in January 2020, the epidemic is still rampant around the world. The Shanghai Expert Consensus on Comprehensive Treatment and Management of Corona Virus Disease 2019 was issued in early March 2020, which provided the guidance of the standardized treatment and rational medication for COVID-19. The administration of " four agents (glucocorticoids, heparin, high-dose vitamin C, Interferon-κ) and one peptide (thymic peptide)" recommended by the consensus is the key to successfully block and treat critical illness.
